logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Y. Pointreau

Universite de Montpellier
H指数:31
被引数:5,591

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discontinuation of the double-blind, placebo-controlled randomized, phase III GORTEC 2022–01 trial of radiotherapy-cetuximab and xevinapant in patients with locally advanced squamous cell carcinoma of the head and neck, unfit for cisplatin

在局部晚期头颈鳞状细胞癌且不适合顺铂治疗的患者中，关于放射治疗联合西妥昔单抗和xevinapant的双盲、安慰剂对照随机III期GORTEC 2022–01试验的终止。

Radiotherapy and Oncology
IF5.3
2026-03-260
PRE
Y. Pointreau; A. Larnaudie; X.S. Sun; F. Rolland; P. Boisselier; Y. Tao; C. Hugo; J. Bourhis
Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study

推动SBRT在照射区域治疗淋巴结寡复发前列腺癌的边界：CYGNUS多中心回顾性研究的结果

International Journal of Radiation Oncology*Biology*Physics
IF0
2026-03-190
PRE
Ewen Anger; Stephane Supiot; Quentin Josset; David Pasquier; Loïg Vaugier; François-Georges Riet; Yoann Pointreau; Amandine Ruffier; Geneviève Loos; Mario Terlizzi; Pierre Blanchard; Etienne Martin; Paul Sargos; Marie Guerni; Ulrike Schick; Guillaume Bera; Julien Roman; Igor Latorzeff; Gilles Créhange; Joël Castelli
Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trial

分次分割低分割放疗与标准放疗在脆弱老年头颈部鳞状细胞癌患者中的比较（ELAN-RT试验）：一项非劣效性、多中心、开放标签、随机对照试验

The Lancet Healthy Longevity
IF0
2026-02-160
OAAI
Cécile Ortholan; Anne Aupérin; Yungan Tao; Sophie Renard; Yoann Pointreau; Cédrik Lafond; Guillaume Bera; Pierre Boisselier; Karen Benezery; Séverine Racadot; Florence Huguet; Marc Bollet; Antoine Laurent Braccini; Cédric Khoury; Stéphane Jacquot; Julie Villa; Laurent Martin; Alessia Di Rito; Nadia Wiazzane; Aurore Goineau
Radiotherapy of sinonasal cancers: 2025 update

鼻窦癌的放射治疗：2025年更新

CANCER RADIOTHERAPIE
IF1.4
2025-11-010
PRE
Larnaudie, Audrey; Carsuzaa, Florent; Delaby, Nolwenn; Costes-Martineau, Valerie; Dore, Melanie; Dupin, Charles; Nguyen, France; Blanchard, Pierre; Pointreau, Yoann; De Gabory, Ludovic; Thariat, Juliette
Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma

健康相关生活质量结局：来自KEYNOTE-412的研究——头颈鳞状细胞癌患者接受含或不含有pembrolizumab的化疗与放疗联合治疗的结果

Frontiers in Oncology
IF3.3
2025-10-060
OAAI
J.-P. Machiels; Y. Tao; L. Licitra; B. Burtness; M. Tahara; D. Rischin; G. V. Alves; I. P. F. Lima; B. G. M. Hughes; Y. Pointreau; S. Aksoy; S. Laban; R. Greil; M. Burian; M. Hetnal; J.-P. Delord; R. Mesia; M. Taberna; J. Waldron; C. Simon; V. Gregoire; K. Harrington; C. M. Black.; J. M. Norquist; A. Wang; B. Gumuscu; B. Bidadi; L. L. Siu

研究方向

暂未获取到该数据
J
Jean Bourhis
H 指数:99论文数:1,058被引数:5.2万
J
Juliette Thariat
H 指数:50论文数:926被引数:1.2万
A
Alexandre Coutté
H 指数:18论文数:157被引数:1,686
F
F. Huguet
H 指数:34论文数:332被引数:6,778
Y
Yungan Tao
H 指数:40论文数:186被引数:5,402
J
J. Castelli
H 指数:29论文数:223被引数:2,881
M
M. Lapeyre
H 指数:39论文数:346被引数:5,721
C
Caroline Even
H 指数:38论文数:393被引数:1.2万
S
S. Racadot
H 指数:24论文数:226被引数:2,526
M
M. Alfonsi
H 指数:31论文数:163被引数:6,306